Global News

Elan acknowledges Royalty’s proposal

Monday, February 25, 2013 10:57 AM

The board of Elan, a biotechnology company based in Ireland, has acknowledged the announcement by Royalty Management regarding an indicative, conditional, proposal which may or may not lead to an offer being made for the entire issued share capital of Elan.

More... »


MJFF launches new funding opportunities for Parkinson's research

Monday, February 25, 2013 09:31 AM

The Michael J. Fox Foundation (MJFF) has launched four new funding programs focused on driving forward research toward transformative treatments and a cure for Parkinson's disease (PD).

More... »


Neurovance receives patent for EB-1020, initiates ADHD trial

Friday, February 22, 2013 01:59 PM

The United States Patent and Trademark Office (USPTO) has issued Neurovance, a Cambridge, Mass.-based company spun out of Euthymics Bioscience, a notice of allowance for a composition of matter patent for EB-1020, providing proprietary protection for EB-1020 through July 2026.

More... »

UCB and ConfometRx announce new R&D partnership

Friday, February 22, 2013 12:13 PM

UCB, a Belgium-based biopharmaceutical company, has sealed a research agreement with Santa Clara, Calif.-based ConfometRx to enable the discovery of novel medicines addressing unmet medical needs in neuroscience.

More... »

Merck, Samsung Bioepis ink biosimilars development agreement

Friday, February 22, 2013 11:45 AM

Global healthcare company Merck and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, entered into an agreement to develop and commercialize multiple pre-specified and undisclosed biosimilar candidates.

More... »

Abbott, Janssen, Pharmacyclics to develop companion test for leukemia therapy

Friday, February 22, 2013 11:16 AM

Global healthcare company Abbott has formed a collaboration with Janssen Biotech and Pharmacyclics, a biopharmaceutical company based in Sunnyvale, Calif., to explore the benefits of Abbott's proprietary FISH (fluorescence in situ hybridization) technology for use in developing a molecular companion diagnostic test to identify patients with a genetic subtype of chronic lymphocytic leukemia (CLL), the most common form of adult leukemia.

More... »

ELC Group launches clinical trials services

Friday, February 22, 2013 10:19 AM

ELC Group, a provider of regulatory affairs consulting services, has launched a new clinical trials service for pharmaceutical customers worldwide.

More... »

BMS appoints Judge as senior vice president, human resources

Thursday, February 21, 2013 08:00 AM

Global biopharmaceutical company Bristol-Myers Squibb (BMS) has appointed Ann Powell Judge as senior vice president, Human Resources.

More... »

The Avoca Group selects Sitrof Technologies as strategic partner

Wednesday, February 20, 2013 02:51 PM

Sitrof Technologies, a provider of IT and document management solutions for the life sciences industry, and The Avoca Group, a consulting and research organization specializing in clinical outsourcing and alliance management, have formed a strategic partnership specifically tailored for the life sciences industry.

More... »

Québec invests in public-private partnership for personalized cancer medicine

Wednesday, February 20, 2013 10:55 AM

The Québec government has invested $10 million in the Personalized Medicine Partnership for Cancer (PMPC), a public-private partnership focused on establishing an integrated approach for the development and implementation of clinical biomarkers and other personalized healthcare solutions to improve the outcome and cost-efficiency of healthcare services provided to cancer patients.

More... »

`

CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs